Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency is a rare genetic condition that weakens the immune response to certain germs. People with this condition often have recurrent or severe infections from weak mycobacteria, like BCG or environmental nontuberculous mycobacteria, and sometimes Salmonella. Signs usually begin in infancy or childhood and the condition is lifelong, but severity varies. Treatment focuses on targeted antibiotics for infections and interferon‑gamma in some cases, and routine vaccines that use live bacteria are avoided. The outlook depends on infection control and access to care, but many people with this condition do well with prompt treatment and close follow‑up.
Overview
Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiencySymptoms
People with Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency often develop severe, recurrent infections, especially after BCG vaccination or environmental mycobacteria, with prolonged fever, swollen lymph nodes, pneumonia or bone infections, and invasive Salmonella, beginning in childhood.
Outlook and prognosis
Many living with Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency do well with prompt treatment of infections and ongoing preventive care. Risks are higher in early childhood and after certain live vaccines. With specialist follow‑up, infections become less frequent and recovery improves over time.
Causes and risk factors
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency arises from autosomal recessive IL12RB1 mutations. Risk increases with family history, consanguinity, and mycobacterial exposure (BCG, TB); early symptoms of Mendelian susceptibility to mycobacterial diseases may appear after exposure.
Genetic influences
Genetics are central in Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency. It’s caused by inherited, usually autosomal recessive, IL12RB1 gene variants. Family history and carrier status strongly influence risk; genetic testing confirms the diagnosis.
Diagnosis
Doctors suspect it from recurrent or severe mycobacterial infections and family history. Blood immune-function tests support the diagnosis. Genetic diagnosis of Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency is confirmed by IL12RB1 gene testing.
Treatment and drugs
Treatment for Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency focuses on preventing and controlling infections. Doctors often use targeted antibiotics for mycobacteria, antifungals when needed, and regular interferon-gamma injections to boost immune responses. Many also receive tailored vaccines guidance, infection prophylaxis, and close monitoring by immunology specialists.
Symptoms
Repeated or unusually severe infections that take longer to clear are the main day-to-day issue. Features vary from person to person and can change over time. Early features of Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency often include swollen lymph nodes, complications after a BCG vaccine (if given), or unexpected Salmonella infections. Between infections, many people feel well, which can make patterns easy to miss until problems keep returning.
Infections caused by mycobacteria may be unusually severe, widespread, or hard to clear. They can affect lymph nodes, lungs, skin, bones, or the liver.
Where the BCG vaccine is used, the shot site may stay open, drain, or spread to nearby lymph nodes. Some develop fever or signs that the vaccine strain has spread beyond the arm.
Nodes in the neck, armpits, or groin can swell and stay enlarged. They may be tender or form draining sores, especially after infections or vaccines.
Long-lasting or repeated fevers are common during infections, often above 38°C (100.4°F). Many feel unusually tired or weak for days to weeks.
How people usually first notice Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency?
Many families first notice something is wrong when a baby or young child has unusually severe or persistent infections after routine Bacillus Calmette–Guérin (BCG) vaccination, exposure to environmental nontuberculous mycobacteria, or recurrent salmonella infections that don’t match the child’s otherwise healthy appearance. Doctors may pick up the pattern as “opportunistic-type” infections in a child without HIV or other known immune problems, prompting immune function testing. This is often how the first signs of Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency are recognized, with blood tests showing poor interferon-gamma responses confirming the diagnosis.
Types of Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency
People with Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency can present in a few recognizable ways that reflect how the immune pathway is affected. Symptoms don’t always look the same for everyone. Broadly, clinicians describe clinical variants based on whether infections begin in early childhood or later and on the types of germs that cause them. When people search for types of IL12RB1 deficiency, they’re usually asking how these variants differ in timing, triggers, and severity.
Early-onset infections
Symptoms often start in infancy or early childhood after routine BCG vaccination or exposure to environmental mycobacteria. Recurrent fevers, swollen lymph nodes, and slow-to-clear skin or lymph node infections are common. Severe salmonella infections may also occur.
Later-onset infections
Some develop first infections in later childhood, teen years, or adulthood, often after environmental exposure rather than vaccination. Illness may be milder at first but can flare with deeper lymph node or bone involvement. The pattern can shift over time as exposures change.
BCG-predominant disease
Problems emerge soon after newborn BCG vaccination, with persistent ulcers at the injection site and nearby lymph node swelling. Spread beyond the skin can happen if not recognized. Not everyone will experience every type.
Environmental mycobacteria
Illness follows contact with non-tuberculous mycobacteria in water or soil, leading to chronic lymph node swelling, skin lesions, or lung issues. Infections can be stubborn and recur after treatment. Loved ones may recognize certain types sooner than the person experiencing them.
Salmonella-predominant
Repeated bloodstream or deep-tissue infections with salmonella stand out more than mycobacterial illness. Fevers, abdominal pain, or diarrhea may come and go between antibiotic courses. Doctors may suspect IL12RB1 deficiency when these infections recur without a clear trigger.
Fungal tendency
Some have additional infections like mucocutaneous candidiasis, with thrush or nail and skin yeast infections. These are usually less severe but may be frequent or persistent. Keeping track of which type you experience most can help your care team tailor prevention and treatment.
What genetics can tell you about symptoms
Some people with complete IL12RB1 deficiency tend to get repeated, sometimes severe infections from weak mycobacteria (like BCG vaccine strains) and certain salmonella, because their immune cells can’t “hear” the IL-12/IL-23 signal to activate. Specific IL12RB1 mutations break the IL-12 receptor’s beta-1 subunit, blocking interferon-gamma production and weakening infection control.
Causes and risk factors
The core cause is an inherited change in both copies of the IL12RB1 gene.
Genes set the stage, but environment and lifestyle often decide how the story unfolds.
This causes Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency and weakens the body’s defense against certain germs.
Exposure to mycobacteria from BCG vaccination, contact with tuberculosis, nontuberculous germs in soil or water, and Salmonella in undercooked poultry or eggs raises infection risk.
Key risk factors for Mendelian susceptibility to mycobacterial diseases include a family history, parental relatedness, and living in places with higher exposure to these germs.
Environmental and biological risk factors
This section explains environmental and biological factors that may slightly raise the chance of being born with Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency. Some risks are carried inside the body, others come from the world around us. It focuses on risks rather than early symptoms of Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency. Because this condition is very rare, evidence is limited; the items below reflect well-accepted science on what can increase rare changes around conception.
Conception at an older age, especially for the father, can raise the chance of new biological changes in sperm or eggs. This slightly increases the likelihood of rare conditions present from birth.
Intensive radiation exposure to either parent before conception can damage reproductive cells. This can increase the chance of new changes occurring when the embryo first forms.
Whole-body treatments such as radiation therapy or certain chemotherapy can temporarily harm sperm or eggs. Waiting periods before conception are often advised to allow recovery and reduce the chance of new changes at conception.
High-level exposure to cell-damaging substances like some solvents or heavy metals can injure reproductive cells. Such exposure before conception may raise the chance of rare changes at the start of development.
Genetic risk factors
Families sometimes notice unusual or severe infections in a child and want to understand the genetic ‘why.’ Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency happens when both copies of a single gene don’t work, weakening a key immune signal. Some risk factors are inherited through our genes.
IL12RB1 variants: Harmful changes in both copies of the IL12RB1 gene prevent the IL-12 receptor beta 1 from working. This blocks IL-12/IL-23 signals that normally spark interferon-gamma, a key anti-mycobacterial defense.
Autosomal recessive pattern: A child is affected when they inherit one nonworking copy of IL12RB1 from each parent. This autosomal recessive pattern underlies Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency.
Complete loss variants: Changes that stop the protein from being made cause complete IL12RB1 deficiency. These abolish receptor function and lead to marked vulnerability to mycobacterial infections.
Carrier state: Carriers usually have no symptoms because one working copy is enough. Two carriers together can have a child with Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency.
Family history clues: Having a sibling or close relative with IL12RB1 deficiency raises the chance that others in the family are carriers or affected. Targeted testing for the known family variant can clarify who is at higher genetic risk.
Shared ancestry risk: Parents who are related or from the same small community may share the same IL12RB1 variant. This increases the likelihood that a child inherits two nonworking copies.
Founder variants: In some populations, a single IL12RB1 change became more common over generations. This can increase genetic risk factors for Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency within that ancestry.
Variable severity: Even with the same IL12RB1 variants, age at first infection and severity can differ. People with the same risk factor can have very different experiences.
Lifestyle risk factors
Lifestyle habits do not cause this condition, but they can influence infection frequency, recovery, and complications. Thoughtful choices around diet, activity, rest, and substance use can support immune defenses and reduce exposure to foodborne and respiratory pathogens. In this context, understanding the lifestyle risk factors for Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency helps tailor daily routines to lower infection risk.
Adequate calories, protein, and micronutrients (especially vitamin D, A, zinc) support barrier function and phagocyte activity that help contain mycobacterial and Salmonella infections. Malnutrition can worsen infection severity and slow recovery.
Avoiding undercooked eggs, meat, and unpasteurized dairy lowers Salmonella risk, a known pathogen in il12rb1 deficiency. Careful handling, refrigeration, and reheating reduce bacterial load that could trigger invasive disease.
Regular moderate exercise may improve lung clearance and overall resilience during and between infections. Overexertion during acute illness can delay recovery and increase complications.
Consistent, sufficient sleep helps regulate inflammatory responses and improves vaccine and infection recovery responses. Short or disrupted sleep is linked with higher respiratory infection risk and may worsen outcomes when exposed to mycobacteria.
Risk prevention
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency can’t be prevented at the genetic level, but you can lower the risk of serious infections and complications. Most strategies focus on avoiding certain exposures, using the right vaccines, and having a rapid-response plan for fevers, cough, or stomach illness. Prevention works best when combined with regular check-ups. Families may also consider genetic counseling to understand future risks and options.
Skip the BCG vaccine and other live bacterial vaccines because they can cause severe infection in IL12RB1 deficiency. Ask for a medical letter to document this in maternity and travel settings.
Keep up to date with inactivated vaccines like flu shots and pneumococcal vaccines to reduce common infections. Household members should be fully vaccinated to add a ring of protection.
Reduce salmonella risk by avoiding undercooked eggs, poultry, and unpasteurized dairy, and by washing produce well. Use safe water for drinking and brushing teeth, especially when traveling.
Avoid close contact with people who have active tuberculosis and crowded settings with poor ventilation if TB rates are high. Seek testing and medical advice after any known exposure.
Transmission
Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency is inherited, not contagious. It follows an autosomal recessive pattern: a child is affected when both parents carry one nonworking copy of the IL12RB1 gene, creating a 25% chance in each pregnancy that the child will have the condition (carriers typically stay well). New (de novo) changes in the gene are uncommon, but they can happen; a genetics visit can help families understand how Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency is inherited and discuss testing options. People with this condition are more prone to mycobacterial infections (for example, after BCG vaccination or from environmental mycobacteria); the genetic condition itself cannot be “caught,” and whether any infection is contagious depends on the germ involved (tuberculosis can spread, while many environmental mycobacteria do not).
When to test your genes
Test if you’ve had severe or unusual infections with BCG vaccine, nontuberculous mycobacteria, or Salmonella, especially in childhood or after live vaccines. Test if a close relative has confirmed IL12RB1 deficiency or similar infections. Test before planning immune‑modulating therapy or if standard treatments repeatedly fail.
Diagnosis
When this condition is present, clues often appear as unusual, repeat, or severe infections that don’t fit the typical pattern—especially after a BCG vaccine or with nontuberculous mycobacteria. Doctors build the diagnosis from the clinical story plus targeted immune tests, then confirm it with a gene test when possible. Genetic testing may be offered to clarify risk or guide treatment. A genetic diagnosis of Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency usually blends these pieces into a clear picture.
Recurrent, severe, or widespread infections with mycobacteria or Salmonella raise suspicion. Early symptoms of this condition can include illness after routine BCG vaccination or frequent fevers with deep lymph node swelling. Patterns that don’t respond as expected to standard antibiotics strengthen concern.
Doctors review past infections, vaccine reactions, travel, and exposure risks in detail. They look for episodes of lymph node, bone, liver, or skin involvement that suggest disseminated mycobacterial disease. A detailed family and health history can help connect scattered clues.
Initial blood tests check white cell counts, inflammatory markers, and antibodies to rule out common immune problems. Normal results here do not exclude IL12RB1 deficiency. These tests help guide which specialized studies to do next.
Specialized labs assess how immune cells respond to signals like interleukin‑12 and interleukin‑23. Poor interferon‑gamma production after stimulation supports the diagnosis of IL12RB1 pathway problems. Results are interpreted alongside the clinical picture.
Stages of Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency does not have defined progression stages. Instead, infections tend to come in episodes, often triggered by exposure to the BCG vaccine or environmental mycobacteria, and the pattern can vary widely from person to person over time. Early symptoms of Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency may include an unusually strong reaction at the BCG shot site, swollen lymph nodes, or recurring Salmonella infections. Doctors usually confirm the diagnosis by reviewing the infection history, doing immune function checks, and ordering genetic testing of IL12RB1; different tests may be suggested to help confirm the cause and guide care.
Outlook and prognosis
Looking at the long-term picture can be helpful. People with Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency often face repeated infections starting in childhood, especially after exposure to BCG vaccine, nontuberculous mycobacteria, or Salmonella. Many living with IL12RB1 deficiency do well between infections, going to school or work normally, then need treatment bursts when fevers, swollen lymph nodes, or skin abscesses flare. Early symptoms of IL12RB1 deficiency may be subtle, like slow-healing skin lesions after a routine vaccine or frequent tummy upsets from Salmonella, and getting a diagnosis early helps tailor prevention and treatment.
The outlook is not the same for everyone, but with consistent care many avoid severe complications. Regular antibiotics when needed, preventive medicines, and interferon‑gamma therapy can lower infection risk and shorten illness when it occurs. Severe mycobacterial infections can be life‑threatening without prompt care, but in centers familiar with this condition, childhood survival is generally high, and many people reach adulthood. Mortality is most often linked to overwhelming infections or lack of access to timely treatment, highlighting the value of vaccination planning and rapid evaluation for new fevers.
Over time, most people learn to recognize early warning signs and seek care before infections escalate. A minority may be considered for stem cell transplant in difficult, recurrent cases, though this is not routine and decisions are highly individualized. Genetic testing can sometimes provide more insight into prognosis. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency is a lifelong immune difference that mainly raises the risk of certain bacterial and fungal infections. Long-term effects vary widely, depending on which infections happen and how early they’re recognized. Early symptoms of Mendelian susceptibility to mycobacterial diseases may include swollen lymph nodes after BCG vaccination or repeated fevers from common infections. Many reach adulthood, but the risk of severe or recurrent infections can continue over time.
Ongoing or repeat infections with BCG vaccine strains or environmental mycobacteria can occur. These infections may affect lymph nodes, skin, lungs, or the whole body.
Some develop severe or widespread infection after BCG given in infancy. This can leave long-term scarring or lingering swollen nodes.
People with il12rb1 deficiency are prone to serious Salmonella infections in the blood or organs. These may recur and can cause lasting health effects.
Repeated chest infections can lead to bronchiectasis, where airways widen and scar over time. This may cause ongoing cough, mucus, and breathlessness.
How is it to live with Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency?
Daily life with Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency often revolves around preventing and promptly treating infections, especially from “weak” mycobacteria like BCG or environmental nontuberculous mycobacteria. Many plan ahead for vaccines, travel, and clinic visits, keep antibiotics handy when prescribed, and learn to notice early signs of infection so care starts quickly. Families and close contacts usually become partners in prevention—helping with hand hygiene, avoiding known exposures, and supporting consistent follow-up with infectious disease and immunology teams. With clear care plans, specialist guidance, and a strong support network, many find a steady routine that balances caution with a full, meaningful life.
Treatment and drugs
Treatment for Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency focuses on preventing serious infections, treating active infections quickly, and strengthening the immune response. Doctors typically use prolonged, combination antibiotics to treat infections caused by weak mycobacteria (like BCG or environmental mycobacteria) and other common germs, and may add antifungals if needed. To boost the immune system, many receive interferon‑gamma injections, which can help the body’s defenses coordinate better against these infections. People with this condition also benefit from careful vaccine planning (avoiding live mycobacterial vaccines such as BCG), prompt treatment of fevers or new symptoms, and ongoing follow‑up with infectious disease and immunology specialists. Your doctor can help weigh the pros and cons of each option, including when to consider long-term preventive antibiotics and how to monitor for side effects.
Non-drug treatment
Living with Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency can make routine exposures—like soil, tap water aerosols, or undercooked foods—more risky. Alongside medicines, non-drug therapies can lower infection risk, catch problems early, and support family planning. Plans focus on hygiene, safer food and water, vaccine planning, and avoiding high-risk exposures. Knowing the early symptoms of Mendelian susceptibility to mycobacterial diseases—and when to seek care—can make a real difference.
Wash hands often with soap and water or use an alcohol gel after public transport, toilets, animals, or gardening. Keep nails short and avoid sharing personal items like razors or towels. Consider a well-fitting mask in crowded indoor spaces during outbreaks.
Avoid undercooked meat, poultry, eggs, and unpasteurized dairy to lower Salmonella risk. Rinse produce well, separate raw and cooked foods, and chill leftovers promptly. Use safe water for drinking and brushing teeth or boil if safety is uncertain.
Live mycobacterial vaccines such as BCG should be avoided; discuss vaccine timing before travel or procedures. Inactivated vaccines are generally encouraged, and household members should be fully immunized to reduce exposure. Bring your vaccine plan to all clinics so staff can verify what is safe for you.
Limit contact with aerosolized water from hot tubs, poorly maintained humidifiers, and indoor fountains. Wear gloves and a mask when gardening or handling potting soil, and wash up right after. Avoid contact with unchlorinated natural water where possible.
Your genes may have an impact on how drugs work for you
Genetic differences in IL12RB1 can change how well certain antimicrobials and immune-boosting treatments work, and how likely side effects are. Pharmacogenetic testing may guide dosing and drug choice, helping tailor therapy to your immune pathway.
Pharmacological treatments
Treatment focuses on two goals: clearing infections and strengthening the immune signal that fights mycobacteria. For pharmacologic treatment of Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency, doctors combine targeted antibiotics with immune-boosting interferon-gamma when needed. Doctors adjust treatment plans regularly as infections change or new lab results come in.
Isoniazid, rifampin, ethambutol, and pyrazinamide are typically used together for suspected or confirmed TB, then narrowed based on test results. Courses are long, often many months, and need close monitoring for side effects and liver health.
Azithromycin or clarithromycin with ethambutol plus rifampin (or rifabutin) is a common three-drug backbone. Treatment is prolonged and tailored to the exact species and drug-susceptibility testing.
For local or disseminated BCG disease after vaccination, combinations usually include isoniazid with rifampin and ethambutol; pyrazinamide is generally avoided for BCG. Therapy is guided by cultures and may require many months.
Because Salmonella infections are more frequent in this condition, antibiotics such as ceftriaxone, ciprofloxacin, or trimethoprim–sulfamethoxazole are used based on local resistance patterns. Longer courses help prevent relapse, and doctors often repeat cultures to confirm clearance.
Genetic influences
Genetically, this condition happens when both copies of the IL12RB1 gene don’t work, which disrupts a key immune signal your body uses to fight certain mycobacteria and some other germs. It follows an autosomal recessive pattern: parents are usually healthy carriers, and with each pregnancy there’s a 25% (1 in 4) chance a child will be affected. Carriers typically have no symptoms. Severity can differ widely, even among siblings; even with the same gene change, people can experience infections at different ages or intensities. A detailed family history and targeted genetic testing of the IL12RB1 gene can confirm the diagnosis and identify carriers; genetic testing for Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency may also guide treatment plans and vaccine decisions. Because it is inherited, relatives may consider carrier testing before pregnancy or early in life, especially in families where severe reactions to the BCG vaccine or repeated Salmonella infections have occurred. Genetic counseling can help you understand your family’s chances in future pregnancies and what the results mean for day-to-day care.
Is Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency genetic?
Genetics are central in Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency. It’s caused by inherited, usually autosomal recessive, IL12RB1 gene variants. Family history and carrier status strongly influence risk; genetic testing confirms the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For people living with this condition, treatment is shaped by the immune pathway that isn’t working, not only by the germ causing the infection. Alongside medical history and culture results, genetic testing can help personalize treatment. In Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, the missing IL‑12/IL‑23 signal means interferon‑gamma can help the immune system respond, whereas IL‑12 or IL‑23 medicines are unlikely to help and drugs that block these signals are usually avoided. Pharmacogenetic testing in Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency is most useful for antibiotic choices: for example, differences in a common liver‑enzyme gene can change how quickly someone processes isoniazid, which may guide dosing and reduce side‑effect risk. If an aminoglycoside (such as amikacin) is needed, rare mitochondrial DNA changes can greatly raise the risk of hearing loss, so testing may be discussed before long courses. Live mycobacterial vaccines (like BCG) are not given, and medicines that weaken the immune system, especially anti‑TNF drugs, are used only with great caution.
Interactions with other conditions
People living with Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency are more likely to run into certain infections that can influence each other. Tuberculosis or BCG-related infection after newborn vaccination can occur alongside repeated Salmonella infections, and each illness can make recovery from the other slower and more complicated. Doctors call it a “comorbidity” when two conditions occur together, and in this condition, mycobacterial disease and Salmonella are the most common pairing. Some also have trouble with certain fungal infections, like persistent thrush, which can flare during or after treatment for a bacterial infection.
Interactions with other diseases matter for treatment choices. For example, medicines that dampen the immune system, such as anti–TNF drugs used for arthritis or inflammatory bowel disease, can sharply raise the risk of severe mycobacterial infection in people with this condition. If you’re being treated for TB or a Salmonella infection, your team may coordinate antibiotics and immune-boosting therapy to lower relapse risk and watch for early symptoms of CONDITION, such as fevers that return, new swollen lymph nodes, or lingering diarrhea. Talk with your doctor about how your conditions may influence each other, especially before starting any new medication or live vaccine.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described stubborn infections that lingered far longer than expected after routine childhood illnesses or vaccines. In some families, a child would recover slowly from a vaccine-related sore at the arm, or keep getting fevers after minor infections, while brothers or cousins had similar stories. Families and communities once noticed patterns, even when there was no name for them.
From early written records to modern studies, doctors linked these unusually severe, repeat infections to certain bacteria, especially those in the mycobacteria group. Before antibiotics and vaccines, these infections could be life-threatening. As vaccines became common, a few children developed unusually persistent reactions to the bacille Calmette–Guérin (BCG) vaccine used in many countries, which hinted that something about their immune defenses worked differently.
Initially understood only through symptoms, later research in the 1990s and 2000s showed that some people lacked a key pathway the immune system uses to call for backup, particularly against mycobacteria. Scientists traced these cases to a missing or nonworking part of a receptor on immune cells known as IL-12 receptor beta-1. When both copies of the gene were affected, the signal to mount a strong defense against specific germs was blunted, explaining why infections were unusually severe or kept coming back.
With each decade, research broadened from single case reports to families across different regions, revealing that Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency occurs worldwide, though it remains uncommon. Genetic testing confirmed that the condition follows an autosomal recessive pattern: parents without symptoms can carry one altered copy, and a child who inherits two altered copies is affected.
Over time, descriptions became more precise. Doctors learned to look for early symptoms of Mendelian susceptibility to mycobacterial diseases due to complete il12rb1 deficiency after BCG vaccination reactions, recurrent nontuberculous mycobacterial infections, or severe illness from certain salmonella species. These clinical clues, paired with lab tests showing a weak immune signaling response, led to a clear diagnosis that previously would have been missed or labeled simply as “unusual infections.”
In recent decades, awareness has grown as immunology advanced and more centers offered genetic testing. This history shaped today’s care: prompt recognition, targeted antibiotics, careful vaccine planning, and family counseling. Knowing the condition’s history helps explain why a pattern of “just hard-to-shake infections” became the key to uncovering a specific, inherited immune difference—and why early evaluation now makes a real difference for many living with this condition.